131 related articles for article (PubMed ID: 20960505)
1. Fluorescence cystoscopy for nonmuscle invasive bladder cancer: is the honeymoon over for the blue light special?
Shah JB; Kamat AM
Cancer; 2011 Mar; 117(5):882-3. PubMed ID: 20960505
[No Abstract] [Full Text] [Related]
2. Incorporating fluorescence cystoscopy for the diagnosis of bladder cancer into clinical practice.
Karl A; Zaak D; Stief CG
Nat Clin Pract Urol; 2008 Aug; 5(8):424-5. PubMed ID: 18577979
[No Abstract] [Full Text] [Related]
3. Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations.
Witjes JA; Redorta JP; Jacqmin D; Sofras F; Malmström PU; Riedl C; Jocham D; Conti G; Montorsi F; Arentsen HC; Zaak D; Mostafid AH; Babjuk M
Eur Urol; 2010 Apr; 57(4):607-14. PubMed ID: 20116164
[TBL] [Abstract][Full Text] [Related]
4. Improved detection and reduced early recurrence of non-muscle-invasive bladder cancer using hexaminolaevulinate fluorescence cystoscopy: results of a multicentre prospective randomized study (PC B305).
Mostafid H; Bunce C;
BJU Int; 2009 Oct; 104(7):889-90. PubMed ID: 19549121
[No Abstract] [Full Text] [Related]
5. Blue-sky thinking about blue-light cystoscopy.
Thomas K; O'Brien T
BJU Int; 2009 Oct; 104(7):887-9. PubMed ID: 19583718
[No Abstract] [Full Text] [Related]
6. Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer.
Mark JR; Gelpi-Hammerschmidt F; Trabulsi EJ; Gomella LG
Can J Urol; 2012 Apr; 19(2):6227-31. PubMed ID: 22512972
[TBL] [Abstract][Full Text] [Related]
7. The role of hexylaminolaevulinate in the diagnosis and follow-up of non-muscle-invasive bladder cancer.
Bunce C; Ayres BE; Griffiths TR; Mostafid H; Kelly J; Persad R; Kockelbergh R
BJU Int; 2010 Feb; 105 Suppl 2():2-7. PubMed ID: 20089091
[No Abstract] [Full Text] [Related]
8. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH
J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971
[TBL] [Abstract][Full Text] [Related]
9. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?
Loidl W; Schmidbauer J; Susani M; Marberger M
Eur Urol; 2005 Mar; 47(3):323-6. PubMed ID: 15716195
[TBL] [Abstract][Full Text] [Related]
10. Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy : A multicenter randomized, double-blind, placebo-controlled trial.
Stenzl A; Penkoff H; Dajc-Sommerer E; Zumbraegel A; Hoeltl L; Scholz M; Riedl C; Bugelnig J; Hobisch A; Burger M; Mikuz G; Pichlmeier U
Cancer; 2011 Mar; 117(5):938-47. PubMed ID: 21351082
[TBL] [Abstract][Full Text] [Related]
11. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
[TBL] [Abstract][Full Text] [Related]
12. The past, present and future of cystoscopy: the fusion of cystoscopy and novel imaging technology.
Lee CS; Yoon CY; Witjes JA
BJU Int; 2008 Nov; 102(9 Pt B):1228-33. PubMed ID: 19035886
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in fluorescence cystoscopy: do novel agents bring a benefit?
Schmidbauer J; Marberger M
Curr Opin Urol; 2007 Sep; 17(5):347-51. PubMed ID: 17762629
[TBL] [Abstract][Full Text] [Related]
14. [Fluorescence guided endoscopy: improvement in the management of bladder cancer].
Uffer M; Jichlinski P
Rev Med Suisse; 2010 Dec; 6(274):2352-4. PubMed ID: 21290867
[TBL] [Abstract][Full Text] [Related]
15. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
Schmidbauer J; Witjes F; Schmeller N; Donat R; Susani M; Marberger M;
J Urol; 2004 Jan; 171(1):135-8. PubMed ID: 14665861
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence cystoscopy: is flexible scope as effective as rigid?
Zlotta A
Eur Urol; 2005 Mar; 47(3):318. PubMed ID: 15716193
[No Abstract] [Full Text] [Related]
17. Fluorescence cystoscopy: is it ready for use in routine clinical practice?
Spiess PE; Grossman HB
Curr Opin Urol; 2006 Sep; 16(5):372-6. PubMed ID: 16905985
[TBL] [Abstract][Full Text] [Related]
18. Bladder carcinoma: MDCT cystography and virtual cystoscopy.
Panebianco V; Sciarra A; Di Martino M; Bernardo S; Vergari V; Gentilucci A; Catalano C; Passariello R
Abdom Imaging; 2010 Jun; 35(3):257-64. PubMed ID: 19471998
[TBL] [Abstract][Full Text] [Related]
19. [Fluorescent cystoscopy and transurethral electroresection in diagnosis and treatment of patients with invasive cancer of the urinary bladder].
Komiakov BK; Gorelov SI; Novikov AI; Gorelov AI; Novikov PB; Strokova LA; Al-Atar T
Urologiia; 2004; (6):37-40. PubMed ID: 15719729
[TBL] [Abstract][Full Text] [Related]
20. Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective Phase II study.
Witjes JA; Moonen PM; van der Heijden AG
Eur Urol; 2005 Mar; 47(3):319-22. PubMed ID: 15716194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]